Target Markets Solvonis focuses on high-burden neuropsychiatric conditions like Alcohol Use Disorder and PTSD, presenting opportunities to engage payer strategies, research collaborations, and companion diagnostics for future trials and potential commercialization.

Clinical-Stage Advantage As a clinical-stage biopharma with a differentiated pipeline of repurposed and novel compounds, there is potential to partner for co-development, licensing deals, or funded research programs to accelerate clinical milestones and reduce time to value.

Investor & Reach Recent activity indicates efforts to expand US investor visibility through Water Tower Research, signaling openness to investor relations services and opportunities to support capital markets communications and buy-side engagement.

Lean Team, Outsourcing With a small headcount, opportunities exist to upsell CRO/CMO partnerships, advisory services, or platform collaborations to scale clinical programs efficiently without substantial in-house ramp.

Financial & Growth Signals Revenue runway appears modest, suggesting sales conversations around strategic partnerships, grant funding, and milestone-based collaborations could be pursued to de-risk investments and align with their growth trajectory.